Abstract Background Parkinson's Disease (PD) is among one of the common comorbidities
in older patients. People with PD may be more vulnerable to severe pneumonia, due to the …

Ivermectin is an FDA‐approved drug for a parasitic disease that has broad antiviral activity.
This study aims to analyse the efficacy of ivermectin in improving the Covid‐19 outcomes …

Vitamin D has many protective properties and potential role against acute lung injury. Low
serum vitamin D is associated with high risk of pneumonia and development of acute …

Background: Persons living with human immunodeficiency virus (PLWH) constitute a
vulnerable population in view of their impaired immune status. At this time, the full interaction …

In December 2019, a novel coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) was initially reported in Wuhan, China …

Abstract Introduction: Coronavirus disease 2019 (COVID-19), a global pandemic, has
infected approximately 10% of the world's population. This comprehensive review aimed to …

Aim: The purpose of the current study is to analyze the potential association between viral
hepatitis and the severity of COVID-19. Background: Coronavirus disease 2019 (COVID-19) …

Новая коронавирусная инфекция SARS-CoV-2 (COVID-19) вошла в историю как одна из
самых смертоносных пандемий человечества. С момента первых сообщений о …

Background: Coronavirus disease 2019 has been a worldwide concern that creates a major
issue in many aspects. It is important to identify severe outcomes' risk factors. To date, viral …